annual current liabilities:
$110.85M-$4.36M(-3.78%)Summary
- As of today (July 27, 2025), NTLA annual total current liabilities is $110.85 million, with the most recent change of -$4.36 million (-3.78%) on December 31, 2024.
- During the last 3 years, NTLA annual current liabilities has fallen by -$14.98 million (-11.91%).
- NTLA annual current liabilities is now -12.41% below its all-time high of $126.55 million, reached on December 31, 2022.
Performance
NTLA Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$112.59M+$1.74M(+1.57%)Summary
- As of today (July 27, 2025), NTLA quarterly total current liabilities is $112.59 million, with the most recent change of +$1.74 million (+1.57%) on March 31, 2025.
- Over the past year, NTLA quarterly current liabilities has increased by +$14.68 million (+14.99%).
- NTLA quarterly current liabilities is now -14.14% below its all-time high of $131.13 million, reached on September 30, 2022.
Performance
NTLA quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NTLA Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.8% | +15.0% |
| 3 y3 years | -11.9% | -10.7% |
| 5 y5 years | +211.1% | +218.9% |
NTLA Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.4% | at low | -14.1% | +22.4% |
| 5 y | 5-year | -12.4% | +211.1% | -14.1% | +101.5% |
| alltime | all time | -12.4% | +4607.1% | -14.1% | +952.8% |
NTLA Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $112.59M(+1.6%) |
| Dec 2024 | $110.85M(-3.8%) | $110.85M(+4.9%) |
| Sep 2024 | - | $105.68M(+0.6%) |
| Jun 2024 | - | $105.09M(+7.3%) |
| Mar 2024 | - | $97.91M(-15.0%) |
| Dec 2023 | $115.21M(-9.0%) | $115.21M(+25.3%) |
| Sep 2023 | - | $91.95M(-7.9%) |
| Jun 2023 | - | $99.85M(-3.4%) |
| Mar 2023 | - | $103.38M(-18.3%) |
| Dec 2022 | $126.55M(+0.6%) | $126.55M(-3.5%) |
| Sep 2022 | - | $131.13M(+6.0%) |
| Jun 2022 | - | $123.76M(-1.9%) |
| Mar 2022 | - | $126.11M(+0.2%) |
| Dec 2021 | $125.83M(+95.8%) | $125.83M(+29.0%) |
| Sep 2021 | - | $97.57M(+31.9%) |
| Jun 2021 | - | $73.96M(+21.8%) |
| Mar 2021 | - | $60.70M(-5.5%) |
| Dec 2020 | $64.25M | $64.25M(+15.0%) |
| Sep 2020 | - | $55.87M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $59.14M(+67.5%) |
| Mar 2020 | - | $35.30M(-0.9%) |
| Dec 2019 | $35.63M(-12.2%) | $35.63M(-5.0%) |
| Sep 2019 | - | $37.52M(-2.5%) |
| Jun 2019 | - | $38.46M(-2.0%) |
| Mar 2019 | - | $39.23M(-3.3%) |
| Dec 2018 | $40.57M(+29.4%) | $40.57M(+56.6%) |
| Sep 2018 | - | $25.91M(+3.0%) |
| Jun 2018 | - | $25.17M(-1.6%) |
| Mar 2018 | - | $25.58M(-18.4%) |
| Dec 2017 | $31.36M(+2.0%) | $31.36M(+21.6%) |
| Sep 2017 | - | $25.79M(-2.2%) |
| Jun 2017 | - | $26.37M(+5.9%) |
| Mar 2017 | - | $24.91M(-18.9%) |
| Dec 2016 | $30.73M(+187.3%) | $30.73M(+35.8%) |
| Sep 2016 | - | $22.63M(+4.7%) |
| Jun 2016 | - | $21.62M(+97.2%) |
| Mar 2016 | - | $10.96M(+2.5%) |
| Dec 2015 | $10.70M(+354.1%) | $10.70M |
| Dec 2014 | $2.35M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual current liabilities year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly current liabilities year-on-year change?
What is Intellia Therapeutics, Inc. annual total current liabilities?
The current annual current liabilities of NTLA is $110.85M
What is the all time high annual current liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual total current liabilities is $126.55M
What is Intellia Therapeutics, Inc. annual current liabilities year-on-year change?
Over the past year, NTLA annual total current liabilities has changed by -$4.36M (-3.78%)
What is Intellia Therapeutics, Inc. quarterly total current liabilities?
The current quarterly current liabilities of NTLA is $112.59M
What is the all time high quarterly current liabilities for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly total current liabilities is $131.13M
What is Intellia Therapeutics, Inc. quarterly current liabilities year-on-year change?
Over the past year, NTLA quarterly total current liabilities has changed by +$14.68M (+14.99%)